Bellerophon Therapeutics competitors
Bellerophon Therapeutics Competitors include ITeos Therapeutics, MultiCell Technologies, Hedgepath Pharmaceuticals and Syneos Health.
Add company...
You can compare up to 12 companies. Please remove a company to add a new one
| Save ComparisonClear all |  Bellerophon Therapeutics Bellerophon Therapeutics is a clinical-stage biotherapeutics company focused on developing innovative products at the intersection of drugs and devices that address significant unmet medical needs in the treatment of cardiopulmonary diseases. |  ITeos Therapeutics ITeos Therapeutics is a biopharmaceutical company whose work is dedicated to designing and developing next generation immunotherapies. |  MultiCell Technologies MultiCell Technologies, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics and discovery tools that address unmet medical needs for the treatment of neurological disorders, hepatic disease and cancer. |  Hedgepath Pharmaceuticals HedgePath Pharma is a clinical stage biopharma company that discovers, develops & plans to commercialize innovative therapeutics for patients with cancer. |  Syneos Health Syneos Health, a contract research organization, provides various clinical development services for the biopharmaceutical and medical device industries. |
Founding Date | Founding Date 2009 | Founding Date 2011 | Founding Date 1962 | Founding Date 1992 | Founding Date 2010 |
Type | Type Public | Type Private | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Warren, US HQ | Locations Charleroi, BE HQ Cambridge, US | Locations Woonsocket, US HQ | Locations Tampa, US HQ | Locations Raleigh, US HQ |
Employees | Employees 209% decrease | Employees 434% decrease | Employees 2 | Employees 9 | Employees 6,800 |
Valuation ($) | Valuation ($) 63.4 m | Valuation ($) N/A | Valuation ($) 716.9 k | Valuation ($) 5.2 m | Valuation ($) 4.5 b |
Twitter followers | Twitter followers N/A | Twitter followers N/A | Twitter followers N/A | Twitter followers 57 | Twitter followers 12.1 k |
Financial ⚠ | |||||
Net income | Net income ($54.8m) (FY, 2017) | Net income N/A | Net income N/A | Net income ($5.1m) (FY, 2017) | Net income ($138.5m) (FY, 2017) |
Funding | |||||
Total funding raised | Total funding raised $ 80m | Total funding raised $ 78.1m | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profileDownload Excel
View company profiles
ITeos Therapeutics
HQ
Charleroi, BE
Employees
43↓ 4% decrease
ITeos Therapeutics is a biopharmaceutical company whose work is dedicated to designing and developing next generation immunotherapies.
View companyMultiCell Technologies
HQ
Woonsocket, US
Employees
2
MultiCell Technologies, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics and discovery tools that address unmet medical needs for the treatment of neurological disorders, hepatic disease and cancer.
View companyHedgepath Pharmaceuticals
HQ
Tampa, US
Employees
9
HedgePath Pharma is a clinical stage biopharma company that discovers, develops & plans to commercialize innovative therapeutics for patients with cancer.
View companySyneos Health
HQ
Raleigh, US
Employees
6,800
Syneos Health, a contract research organization, provides various clinical development services for the biopharmaceutical and medical device industries.
View company